[1] Moris D,Palta M,Kim C,et al.Advances in the treatment of intrahepatic cholangiocarcinoma:An overview of the current and future therapeutic landscape for clinicians[J].CA Cancer J Clin,2023,73(2):198-222.
[2] Kelley RK,Bridgewater J,Gores GJ,et al.Systemic therapies for intrahepatic cholangiocarcinoma[J].J Hepatol,2020,72(2):353-363.
[3] Hewitt DB,Brown ZJ,Pawlik TM.Surgical management of intrahepatic cholangiocarcinoma[J].Expert Rev Anticancer Ther,2022,22(1):27-38.
[4] 陈家璐,于小鹏,唐玥,等.术前血清学联合影像学检查预测肝内胆管癌根治性切除术后患者生存获益的研究[J].中国普通外科杂志,2023,32(8):1156-1166.
[5] 杜磊,马富平,晁延军,等.淋巴细胞和C反应蛋白比值在肝内胆管癌根治性手术预后中的意义[J].肝胆胰外科杂志,2021,33(9):528-532.
[6] 胡兴龙,王胜智,吴敏良,等.肝内胆管细胞癌患者术后的预后影响因素研究[J].中国普通外科杂志,2020,29(3):377-382.
[7] 沈锋,张汉,杨田,等.肝内胆管癌的外科综合治疗[J].中华消化外科杂志,2018,17(3):213-218.
[8] 李学建,张城硕,李晓航,等.影响肝胆管细胞癌手术预后的临床病理学因素分析[J].局解手术学杂志,2022,31(1):65-70.
[9] 邹志邈,陈星,李夏,等.肝内胆管结石影响肝内胆管癌患者手术预后的回顾性分析[J].肝胆胰外科杂志,2024,36(6):326-330,336.
[10] 李起,张瑞,陈晨,等.肝内胆管细胞癌预后影响因素分析及生存列线图建立[J].国际外科学杂志,2020,47(2):86-92,封4.
[11] 唐啸. 根治性切除术辅助肝动脉化疗栓塞治疗肝内胆管细胞癌的疗效和预后分析[J].临床肝胆病杂志,2015,31(2):236-239.
[12] Moazzam Z,Alaimo L,Endo Y,et al.Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intra-hepatic Cholangiocarcinoma[J].J Am Coll Surg,2023,236(4):804-813.
[13] Li H,Liu R,Qiu H,et al.Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocar-cinoma After Hepatic Resection:A Retrospective,Multi-Institutional Study[J].Front Oncol,2022,12:829407.
[14] 李风伟,邹奇飞,薛辉,等.术前糖类抗原19-9水平评估不同甲胎蛋白水平肝细胞癌肝切除术后患者的预后[J].第二军医大学学报,2018,39(6):603-609.
[15] Miyazaki K,Morine Y,Imura S,et al.Preoperative lym-phocyte/C-reactive protein ratio and its correlation with CD8(+) tumor-infiltrating lymphocytes as a predictor of prognosis after resection of intrahepatic cholangiocar-cinoma[J].Surg Today,2021,51(12):1985-1995.
[16] Lu LH,Zhong C,Wei W,et al.Lymphocyte-C-reactive protein ratio as a novel prognostic index in intr-ahepatic cholangiocarcinoma:A multicentre cohort study[J].Liver Int,2021,41(2):378-387.
[17] 张蔡羽天,邱虎,蔡高科,等.基于肿瘤负荷评分评估肝癌切除或移植术后的预后[J].武汉大学学报(医学版),2023,44(10):1209-1213,1239.
[18] 陈青,王征,周俭.肿瘤负荷评分在获得根治性切除肝内胆管癌患者预后预测中的价值[J].肝胆胰外科杂志,2022,34(7):399-405.
[19] 袁浩,张号枫,李青山,等.系统免疫炎症指数联合肿瘤负荷评分对肝内胆管癌根治性切除术后患者预后的预测价值[J].中华消化杂志,2024,44(4):257-265.
[20] 刘洪恩,辛大平,彭彬.NLR、PLR和SII在肝癌根治术患者中的表达及与预后的相关性[J].中国医师杂志,2020,22(9):1352-1355.
[21] Tsilimigras D,Moris D,Mehta R,et al.The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma:an international multi-institutional analysis[J].Multicenter Study HPB(Oxford),2020,22(12):1667-1674. |
2025, Vol. 45 
